The Acute Myeloid Leukemia Channel on VJHemOnc is an independent medical education platform, supported with funding from BMS (Silver), and through an educational grant from Jazz Pharmaceuticals. Supporters have no influence on the production of content. The levels of sponsorship listed are reflective of the amount of funding given.
EBMT 2023 | Outcomes following haploidentical & cord blood transplantation in pediatric patients with AML
Antonio Perez-Martinez, MD, PhD, La Paz University Hospital, Madrid, Spain, comments on the outcomes of pediatric patients with acute myeloid leukemia (AML) who have undergone haploidentical and cord blood transplantation. Dr Perez-Martinez explains that both of these procedures lead to similar outcomes and the expertise of each individual center should be considered when selecting between haploidentical and cord blood transplantation. This interview took place at the 49th Annual Meeting of the European Group for Blood and Marrow Transplantation (EBMT) held in Paris, France.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.
